Phase II study of weekly paclitaxel as second-line therapy in patients with advanced non-small cell lung cancer

Giovanni Luca Ceresoli, Vanesa Gregorc, Stefano Cordio, Katia Bruna Bencardino, Stefano Schipani, Cesare Cozzarini, Roberto Bordonaro, Eugenio Villa

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Phase II study of weekly paclitaxel as second-line therapy in patients with advanced non-small cell lung cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences